Skip to main content
. 2021 Oct 9;13(10):1649. doi: 10.3390/pharmaceutics13101649

Figure 3.

Figure 3

The underlying obstacles and corresponding solutions for efficient CRISPR system delivery in the form of plasmid, RNA (Cas9 mRNA, sgRNA), and Cas9 RNP (Created with BioRender.com, accessed on 30 September 2021).